Stephen P Macmillan Hologic Inc (HOLX) insider trading activity

Stephen P Macmillan is Chairman, President and CEO of HOLOGIC INC. Currently has a direct ownership of 1.16 Million shares of HOLX, which is worth approximately $85.4 Million. The most recent transaction as insider was on May 23, 2024, when has been sold 57,875 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.16M

6.61% 3M change

49.99% 12M change

Total Value Held $85.4 Million

STEPHEN P MACMILLAN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 23 2024	SELL Bona fide gift	-	57,875 Reduced 4.76%	1,157,213 Common Stock
Apr 22 2024	SELL Bona fide gift	-	12,000 Reduced 0.98%	1,215,088 Common Stock
Apr 19 2024	SELL Bona fide gift	-	12,000 Reduced 0.97%	1,227,088 Common Stock
Nov 29 2023	SELL Open market or private sale	$3,359,331 $70.41 p/Share	47,711 Reduced 3.71%	1,239,088 Common Stock
Nov 29 2023	BUY Exercise of conversion of derivative security	$1,250,505 $26.21 p/Share	47,711 Added 3.58%	1,286,799 Common Stock
Nov 14 2023	BUY Grant, award, or other acquisition	-	40,832 Added 3.19%	1,239,088 Common Stock
Nov 09 2023	SELL Payment of exercise price or tax liability	$4,422,499 $67.2 p/Share	65,811 Reduced 5.21%	1,198,256 Common Stock

Nov 08 2023	SELL Payment of exercise price or tax liability	$371,525 $68.27 p/Share	5,442 Reduced 0.43%	1,264,067 Common Stock
Nov 07 2023	SELL Payment of exercise price or tax liability	$271,702 $68.37 p/Share	3,974 Reduced 0.31%	1,269,509 Common Stock
Nov 06 2023	BUY Grant, award, or other acquisition	-	24,133 Added 1.86%	1,273,483 Common Stock
Aug 30 2023	SELL Bona fide gift	-	1,064,954 Reduced 46.02%	1,249,350 Common Stock
Nov 30 2022	SELL Open market or private sale	$2,536,620 $75.72 p/Share	33,500 Reduced 1.43%	2,313,970 Common Stock
Nov 11 2022	SELL Open market or private sale	$10,481,313 $75.72 p/Share	138,422 Reduced 5.36%	2,443,825 Common Stock
Nov 11 2022	SELL Payment of exercise price or tax liability	$7,316,235 $75.93 p/Share	96,355 Reduced 3.94%	2,347,470 Common Stock
Nov 11 2022	BUY Exercise of conversion of derivative security	$2,501,010 $26.21 p/Share	95,422 Added 3.62%	2,539,247 Common Stock
Nov 09 2022	SELL Payment of exercise price or tax liability	$416,507 $72.11 p/Share	5,776 Reduced 0.23%	2,486,825 Common Stock
Nov 08 2022	SELL Payment of exercise price or tax liability	$298,672 $73.71 p/Share	4,052 Reduced 0.16%	2,492,601 Common Stock
Nov 07 2022	BUY Grant, award, or other acquisition	-	36,987 Added 1.46%	2,496,653 Common Stock
Nov 01 2022	BUY Grant, award, or other acquisition	-	103,447 Added 4.04%	2,459,666 Common Stock
Nov 12 2021	SELL Payment of exercise price or tax liability	$6,749,281 $73.54 p/Share	91,777 Reduced 3.75%	2,355,893 Common Stock
Nov 11 2021	SELL Payment of exercise price or tax liability	$533,320 $72.61 p/Share	7,345 Reduced 0.3%	2,447,670 Common Stock
Nov 09 2021	SELL Payment of exercise price or tax liability	$297,368 $71.26 p/Share	4,173 Reduced 0.17%	2,455,015 Common Stock
Nov 08 2021	BUY Grant, award, or other acquisition	-	35,146 Added 1.41%	2,459,188 Common Stock
Nov 01 2021	BUY Grant, award, or other acquisition	-	240,732 Added 9.03%	2,424,042 Common Stock
Dec 01 2020	SELL Payment of exercise price or tax liability	$30,631,559 $69.63 p/Share	439,919 Reduced 16.64%	2,203,217 Common Stock

Also insider at

BSX

BOSTON SCIENTIFIC CORP Healthcare

Director

ILMN

ILLUMINA, INC. Healthcare

Director

SPM